Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2011 - 2026)
Ligand Pharmaceuticals' (LGND) Asset Utilization Ratio came in at 0.16 for Q2 2026, down 22.8% from 0.20 a year earlier and down 11.9% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Ligand Pharmaceuticals' Asset Utilization Ratio stood at 0.21, up 10.8% from FY2024.
- In prior years, Ligand Pharmaceuticals' Asset Utilization Ratio was 0.19 in FY2024 (+14.1%), 0.17 in FY2023 (-11.1%), 0.19 in FY2022 (+4.9%) and 0.18 in FY2021 (+58.6%).
- The Q2 2026 figure stands as the lowest quarterly Asset Utilization Ratio since Q2 2024.
- On a year-over-year basis, Asset Utilization Ratio increased in five of the last eight quarters, with growth averaging 6.9%.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q3 2021, with growth of 75.1%; the weakest was Q1 2024, with a decline of 46.3%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.18 (Q1 2026), 0.18 (Q4 2025) and 0.21 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | Ligand Pharmaceuticals | 6.33 Bn | 2.80 Bn | - | 0.16 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16 |
| Mar 31, 2026 | 0.18 |
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 0.20 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.15 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.20 |
| Jun 30, 2023 | 0.23 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.22 |
| Sep 30, 2022 | 0.19 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.19 |
| Dec 31, 2021 | 0.19 |
| Sep 30, 2021 | 0.20 |
API Access
Ligand Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();